FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease
出版年份 2013 全文链接
标题
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease
作者
关键词
-
出版物
HUMAN MOLECULAR GENETICS
Volume 23, Issue 9, Pages 2251-2265
出版商
Oxford University Press (OUP)
发表日期
2013-12-04
DOI
10.1093/hmg/ddt615
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine
- (2013) Fatemeh Hemmati et al. BEHAVIOURAL BRAIN RESEARCH
- Drugs in Development for Relapsing Multiple Sclerosis
- (2013) Rehiana Ali et al. DRUGS
- Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin
- (2013) Nicholas Stephane Caron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis
- (2012) Kenji Chiba et al. Future Medicinal Chemistry
- Serine Phosphorylation Suppresses Huntingtin Amyloid Accumulation by Altering Protein Aggregation Properties
- (2012) Rakesh Mishra et al. JOURNAL OF MOLECULAR BIOLOGY
- Early tolerability and safety of fingolimod in clinical practice
- (2012) Daniel Ontaneda et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells
- (2012) Alexander M. Stessin et al. NEUROSCIENCE LETTERS
- Fingolimod protects cultured cortical neurons against excitotoxic death
- (2012) Luisa Di Menna et al. PHARMACOLOGICAL RESEARCH
- Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
- (2012) R. Deogracias et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice
- (2012) A. Di Pardo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel target for Huntington's disease: ERK at the crossroads of signaling
- (2011) László Bodai et al. BIOESSAYS
- Protein aggregates in Huntington's disease
- (2011) Montserrat Arrasate et al. EXPERIMENTAL NEUROLOGY
- Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
- (2011) Hye Jung Kim et al. FASEB JOURNAL
- Myelin-associated glycoprotein protects neurons from excitotoxicity
- (2011) Pablo H. H. Lopez et al. JOURNAL OF NEUROCHEMISTRY
- Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 Contributes to Dysmyelination in Experimental Models of Huntington's Disease
- (2011) Z. Xiang et al. JOURNAL OF NEUROSCIENCE
- Levels of BDNF Impact Oligodendrocyte Lineage Cells following a Cuprizone Lesion
- (2011) M. W. VonDran et al. JOURNAL OF NEUROSCIENCE
- Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
- (2011) Albert Giralt et al. Molecular Neurodegeneration
- Kinase inhibitors modulate huntingtin cell localization and toxicity
- (2011) Randy Singh Atwal et al. Nature Chemical Biology
- Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease
- (2011) Jeffrey B. Carroll et al. NEUROBIOLOGY OF DISEASE
- Mutant Huntingtin Alters Cell Fate in Response to Microtubule Depolymerization via the GEF-H1-RhoA-ERK Pathway
- (2010) Hemant Varma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
- (2010) Y. Xie et al. JOURNAL OF NEUROSCIENCE
- Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
- (2010) V. Maglione et al. JOURNAL OF NEUROSCIENCE
- Activation of Sphingosine-1-Phosphate 1 Receptor in the Proximal Tubule Protects Against Ischemia-Reperfusion Injury
- (2010) A. Bajwa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-de pend ent Manner
- (2009) Sujoy Lahiri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
- (2009) Leslie Michels Thompson et al. JOURNAL OF CELL BIOLOGY
- Axonal Protective Effects of the Myelin-Associated Glycoprotein
- (2009) T. Nguyen et al. JOURNAL OF NEUROSCIENCE
- Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease
- (2009) D. M. Cummings et al. JOURNAL OF NEUROSCIENCE
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
- (2009) Xiaofeng Gu et al. NEURON
- Central nervous system-directed effects of FTY720 (fingolimod)
- (2008) Veronique E. Miron et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures
- (2007) Anna Maria Brunati et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
- (2007) Kumlesh K. Dev et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search